Advertisement

Parathyroid Hormone PTH Receptor - Biotech, Pharma and Life Science Channel

19:05 EDT 18th June 2013 | BioPortfolio

There are two known parathyroid hormone receptors in mammals termed PTH1R and PTH2R. These receptors bind parathyroid hormone and are members of the GPCR family of transmembrane proteins.
* parathyroid hormone 1 receptor (PTH1R) is the classical PTH receptor, is expressed in high levels in bone and kidney and regulates calcium ion homeostasis through activation of adenylate cyclase and phospholipase C.
* parathyroid hormone 2 receptor (PTH2R) is expressed primarily in the central nervous system, pancreas, testis, and placenta.

Parathyroid Hormone (PTH) Receptor Agonists or PTH Analogs are used to stimulate the PTH receptor for the treatment of osteoporosis or other bone-related diseases. PTH analogs are recombinant and synthetic peptides delivered by injection, inhalation, nasal, oral and transdermal administration. In cases of systemic sclerosis, PTH may stimulate aberrant calcification.

Source; Wikipedia

Add the Parathyroid Hormone News Channel to your RSS reader;


 

News Articles [ 505 Associated News Articles listed on BioPortfolio]

Eating Peanut Butter/Peanuts at Breakfast Helps Control Hunger and Blood Sugar All Day

ALBANY, Ga., June 18, 2013 /PRNewswire/ -- A new study, released in the current British Journal of Nutrition, showed that consuming peanut butter or peanuts for breakfast can control blood sugar...

Celebrity Magazine Editors Attend "Youth Hormone" Conference in Las Vegas

NEW YORK, June 18, 2013 /PRNewswire/ -- What if there was something that could make you look and feel decades — not years, but decades — younger, reduce body fat, boost mood, strength...

Novo Nordisk A/S: Federal Circuit Court rules on patent litigation involving Prandin(R) (repaglinide)

BAGSVAERD, DENMARK -- (Marketwired) -- 06/18/13 -- Today, the U.S. Court of Appeals for the Federal Circuit partially affirmed a 2011 District Court decision, with a 2-1 ruling that a claim in a Novo...

Rockwell Medical Receives $20 Million in New Financing

WIXOM, MI -- (Marketwired) -- 06/18/13 -- Rockwell Medical (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with...

Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients with Hypoparathyroidism

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, yesterd...

Initial Findings from PARADOX, Largest and Most Comprehensive Research Analyzing the Burden of Hypoparathyroidism, Reveals Collection of Nearly 40 Physical, Cognitive, Emotional Symptoms

-- 99% of patients experience multiple symptoms despite taking medications, such as calcium and vitamin D -- -- Patients experience an average of 16 symptoms –...

Aragon Pharmaceuticals Announces Acquisition by Johnson & Johnson

SAN DIEGO, CA -- (Marketwired) -- 06/17/13 -- Aragon Pharmaceuticals Inc., a leader in developing drugs for hormone driven cancers, today announced a definitive agreement with Johnson & Johnson w...

Daily 10 milligram dose of S-equol reduces menopausal symptoms effectively without impacting thyroid and sex hormones

NORTHRIDGE, Calif., June 15, 2013 /PRNewswire-USNewswire/ -- Consuming 10 milligrams (mg) daily of S-equol delivered via a new fermented soy-based nutritional supplement alleviated menopausal sym...

NPS Pharmaceuticals’ President and CEO Dr. Francois Nader Receives Ernst & Young Entrepreneur Of The Year® 2013 Award in New Jersey

-- Award recognizes entrepreneurial excellence in life sciences -- NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies th...

Patients Honor Dr. Todd Darmody, MD for Compassion

FORT LAUDERDALE, Fla., June 14, 2013 /PRNewswire-USNewswire/ -- Patients' Choice has announced that Dr. Todd Darmody, MD was one of a select few physicians honored with the prestigious 2012 Compassion...

Events [0 Results]

None

Companies [ 43 Associated Companies listed on BioPortfolio]

Sequenta, Inc.

Sequenta, Inc. is a privately held company developing and commercializing molecular diagnostic assays based on a proprietary sequencing approach to the profiling of T and B cell r...

Tokai Pharmaceuticals

Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The company’s lead drug candidate, TOK-001, is the first i...

Izun Pharmaceuticals Corporation

Izun Pharmaceuticals is a US based pharmaceutical company with a wholly owned R&D center in Israel. Izun’s technology platform allows it to develop botanical drugs by optimiz...

Opsona Therapeutics Ltd.

Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of majo...

TheAmerican Association of Clinical Endocrinologists (AACE)

The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinic...

Dendreon Corporation

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of no...

Hotze Pharmacy

Hotze Pharmacy, a part of Hotze Enterprises, is leading a wellness revolution in bioidentical hormone replacement therapy by compounding the finest quality of biologically identic...

Tokai Pharmaceuticals, Inc.

Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The company’s lead drug candidate, galeterone (TOK-001), i...

EnVivo Pharmaceuticals, Inc.

EnVivo Pharmaceuticals, Inc. and its subsidiaries (“EnVivo Pharmaceuticals” or “EnVivo”) are dedicated to discovering and developing small molecule therapeutic...

bioTheranostics, Inc.

bioTheranostics discovers, develops, and commercializes a growing array of molecular diagnostic tests for cancer patients. Leveraging its unique expertise in expression profiling...

Clinical Trials [ 1841 Associated Clinical Trials listed on BioPortfolio]

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

RATIONALE: Goserelin blocks hormone production in the ovaries. It is not yet known whether ovarian suppression using goserelin will prevent ovarian failure (early menopause) in women recei...

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer

This randomized phase III trial is studying giving tamoxifen citrate or letrozole together with bevacizumab to see how well it works compared with tamoxifen citrate or letrozole alone in t...

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

This is a phase II, open label, active-controlled, randomized safety and dose finding study of different MOD-4023 dose levels compared to daily r-hGH therapy in pre-pubertal growth hormone...

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

RATIONALE: Aromatase inhibitors, such as letrozole, prevent the formation of estradiol, a female hormone. Giving letrozole together with goserelin, leuprolide, or surgery may be an effecti...

Screening Evaluation for Women With Postpartum Depression

This study evaluates the relationship between mood changes and hormones in women with postpartum depression (PPD). This is an observational study; volunteers who participate will not rece...

Pamidronate to Treat Osteogenesis Imperfecta in Children

This study will evaluate the effect of pamidronate-a drug that decreases bone resorption (breakdown)-on osteogenesis imperfecta. This is a genetic disorder of collagen, the major protein...

Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1

This study will evaluate the safety and effectiveness of insulin-like growth factor-1 (IGF-1) to treat patients with X-linked severe combined immunodeficiency (XSCID). Those who have XSCID...

Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion

This study will evaluate whether the drug mifepristone can improve the symptoms of Cushing's syndrome in people with ectopic adrenal corticotrophin hormone (ACTH) secretion. Cushing's synd...

First Human Dose Trial of NNC0195-0092 in Healthy Subjects

This trial is conducted in Europe. The aim of this trial is to assess safety, tolerability, pharmacokinetics (the exposure of the trial drug in the body) and pharmacodynamics (the effect o...

Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity

Trastuzumab prolongs survival in patients with human epidermal growth factor receptor type 2-positive breast cancer. Sequential left ventricular (LV) ejection fraction (EF) assessment has...

PubMed Articles [ 10383 Associated PubMed Articles listed on BioPortfolio]

Effective treatment of a steroid-induced femoral neck fracture nonunion with a once-weekly administration of teriparatide in a rheumatoid patient: a case report.

INTRODUCTION: Nonunion of femoral neck fractures frequently occurs in elderly patients. In patients with rheumatoid arthritis, reoperation rates after internal fixation of a displaced femoral neck fra...

Macular pathology as a cause of visual impairment?

This article reports a case of a pituitary adenoma as the cause of unilateral visual impairment and concomitant unilateral macular pathology. Pituitary adenomas can be classified into hormone-secretin...

A Detailed Study on Understanding Glycopolymer Library and Con A Interactions.

Synthetic glycopolymers are important natural oligosaccharides mimics for many biological applications. To develop glycopolymeric drugs and therapeutic agents, factors that control the receptor-ligand...

Superantigen-induced steroid resistance depends on activation of phospholipase cβ2.

The glucocorticoid receptor is present in a TCR-associated complex, which includes the Src family tyrosine kinase Lck. Glucocorticoids rapidly dissociate this complex, resulting in the inhibition of c...

Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl Peptide receptor 2/lipoxin a4 receptor.

Endogenous mechanisms regulating the host response during inflammation resolution are critical in ensuring disposal of noxious stimuli and return to homeostasis. In this article, we engineered novel A...

Reciprocal Negative Cross-Talk between Liver X Receptors (LXRs) and STAT1: Effects on IFN-γ-Induced Inflammatory Responses and LXR-Dependent Gene Expression.

Liver X receptors (LXRs) exert key functions in lipid homeostasis and in control of inflammation. In this study we have explored the impact of LXR activation on the macrophage response to the endogeno...

Allelic Variation in KIR2DL3 Generates a KIR2DL2-like Receptor with Increased Binding to its HLA-C Ligand.

Although extensive homology exists between their extracellular domains, NK cell inhibitory receptors killer Ig-like receptor (KIR) 2DL2*001 and KIR2DL3*001 have previously been shown to differ substan...

Critical Roles of a Dendritic Cell Subset Expressing a Chemokine Receptor, XCR1.

Dendritic cells (DCs) consist of various subsets that play crucial roles in linking innate and adaptive immunity. In the murine spleen, CD8α(+) DCs exhibit a propensity to ingest dying/dead cells, pr...

Cell-autonomous regulation of neutrophil migration by the d6 chemokine decoy receptor.

Chemokines, acting on their cognate receptors on infiltrating leukocytes, drive the inflammatory response. We have been interested in determining roles and potential mechanisms for the atypical chemok...

New azole antagonists with high affinity for the P2Y1 receptor.

Five-membered-ring heterocyclic urea mimics have been found to be potent and selective antagonists of the P2Y1 receptor. SAR of the various heterocyclic replacements is presented, as well as side-chai...

Videos

Parathyroid hormone - Wiki Article

Parathyroid hormone, parathormone or parathyrin, is secreted by the chief cells of the parathyroid glands as a polypeptide containing 84 amino acids. It acts...

Medical and Biotech [MESH] Definitions

Transferrin-binding Protein A

A subtype of bacterial transferrin-binding protein found in bacteria. It forms a cell surface receptor complex with TRANSFERRIN-BINDING PROTEIN B.

Transferrin-binding Protein B

A subtype of bacterial transferrin-binding protein found in bacteria. It forms a cell surface receptor complex with TRANSFERRIN-BINDING PROTEIN A.

Bacterial Transferrin Receptor Complex

A complex of proteins that forms a receptor for TRANSFERRIN in BACTERIA. Many pathogenic bacteria utilize the transferrin-binding complex to acquire their supply of iron from serum.

Luteinization

Formation of CORPUS LUTEUM. This process includes capillary invasion of the ruptured OVARIAN FOLLICLE, hypertrophy of the GRANULOSA CELLS and the THECA CELLS, and the production of PROGESTERONE. Luteinization is regulated by LUTEINIZING HORMONE.

Receptors, Eph Family

A large family of receptor protein-tyrosine kinases that are structurally-related. The name of this family of proteins derives from original protein Eph (now called the EPHA1 RECEPTOR), which was named after the cell line it was first discovered in: Erythropoietin-Producing human Hepatocellular carcinoma cell line. Members of this family have been implicated in regulation of cell-cell interactions involved in nervous system patterning and development.

Search BioPortfolio:
Advertisement
review and buy Parathyroid Hormone PTH Receptor market research data and corporate reports here

Channels Quicklinks

Advertisement